2KMM in Horizon 2020 project

2KMM in „Horizon 2020" project

We are pleased to inform that our company is participating in the research project under the biggest EU Research and Innovation programme - "Horizon 2020".

2KMM is a member of an international consortium, coordinated by the Medical University of Zagreb. The consortium consists of 13 partners from 6 European Union member states, assembled to conduct a Phase II, randomized, clinical trial project: Novel Bone Regeneration Drug Osteogrow: Therapeutic Solution for Lumbar Back Pain with the acronym: OSTEOproSPINE.

In this 5 year-long trial with the budget of 6 million EUR, 2KMM will be responsible for the set-up and hosting of an electronic CRF based on our data collection platform - GoResearch™, data management and biostatistics. The start of the project is scheduled for January 2018.

More information on Osteogrow -- an innovative and unique approach towards safe, effective and inexpensive bone regeneration therapy can be found at http://osteogrow.eu/.